RVG

Overview

RVG (RVG29) is a blood-brain barrier-permeable peptide derived from rabies virus glycoprotein , which binds to the α-7 subunit of neuronal nicotinic acetylcholine receptor ( AchR ). RVG efficiently delivers drugs to nerve cells and antigen-presenting cells in a targeted manner, and enhances the efficiency of antigen presentation and drug delivery.

Application

Products | Products > Peptides | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > nAChR | Products > Signaling Pathways > Interleukin Related

Product Information

• Catalog No.: HY-P5623
• CAS No.: 115136-25-9
• Molecular Formula: C141H217N43O43S2
• Molecular Weight: 3266.62
• Purity: 99.81%
• Storage: Sealed storage, away from moisture. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source